Abatacept for the Treatment of Myositis-associated Interstitial Lung Disease

NCT03215927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myositis
Interstitial Lung Disease

Interventions

DRUG: Abatacept
OTHER: Placebo

Sponsor

Rohit Aggarwal, MD

Collaborators

[object Object]